Physician profile
Veronica E Hurtado
NPI 1437388451
$2,110.16
in general payments reported to CMS, 2019-2025
27 companies · $408 in 2025
The $408 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $130 · 2021: $180 · 2022: $334 · 2023: $331 · 2024: $363 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $628.27 | 2022-2025 | |
| Abbvie INC. | $271.00 | 2019-2023 | |
| Pfizer INC. | $194.94 | 2019-2024 | |
| Astellas Pharma US INC | $133.12 | 2022-2024 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $125.90 | 2019-2020 | |
| Millicent US INC | $101.64 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Avion Pharmaceuticals | $81.57 | 2022-2023 | Balcoltra |
| Shield Therapeutics INC | $81.35 | 2023-2024 | Accrufer |
| Exact Sciences Corporation | $67.85 | 2024-2025 | Cologuard Collection Kit |
| Exeltis, USA INC. | $44.26 | 2020-2022 | |
| Hologic Sales and Service, LLC | $41.14 | 2022 | |
| Renovia INC | $40.72 | 2019-2020 | |
| Applied Medical Resources Corporation | $33.50 | 2022 | |
| Evofem Biosciences, INC. | $33.28 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.53 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $21.35 | 2019 | |
| Daiichi Sankyo INC. | $20.14 | 2021 | |
| Mylan Pharmaceuticals INC. | $18.72 | 2020 | |
| Amag Pharmaceuticals, INC. | $18.59 | 2019 | |
| Novo Nordisk INC | $18.40 | 2024 | Wegovy |
| Coopersurgical, INC. | $18.07 | 2021 | |
| Vertical Pharmaceuticals, LLC | $16.71 | 2019 | |
| Biogen, INC. | $16.68 | 2024 | |
| Aspira Women'S Health INC | $16.10 | 2024 | Ova1 |
| Allergan, INC. | $15.47 | 2019 | |
| Mission Pharmacal Company | $14.84 | 2021 | |
| Medline Industries Lp | $13.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Hurtado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.